Universal Medical Financial & Technical Advisory Services Company Limited (”Universal Medical”, HK. 2666) held its first 2018 new respirator presentation in Beijing. Dr. Mi Weidong, Chairman of the 5^th Anesthesiologist Committee under Chinese Medical Doctor Association and Director of Anesthesiology Department of Chinese PLA General Hospital (the 301 Hospital), hosted the meeting which over 20 experts leading anesthesiology area attended the meeting and shared their opinions, including Dr. Guo Xiangyang, Deputy Chairman of the 5^th Anesthesiologist Committee under Chinese Medical Doctor Association and Director of Anesthesiology Department of Peking University Third Hospital and Dr. Feng Yi, Deputy Chairman of the 12^th Anesthesiology Branch under Beijing Medical Doctor Association and Director of Anesthesiology Department of PKU People’s Hospital, etc.

The new arriving TwinStream Respirator and Mostcare Hemodynamics Monitor with Universal Medical acting as their general agent, received much attention from experts.

TwinStream is the only artificial breathing system in the world that is able to work in high frequency and normal frequency at the same time. The system promotes patients’ oxygenation index while preventing carbon dioxide retention, which lifts breathing restrictions during surgery and guarantees patients’ safety.

Mostcare Hemodynamics Monitor is able to closely and completely record and analyze blood pressure condition via Blood Pressure Recording Method. It can also measure SV every heartbeat without any outside calibration or special consumables, which greatly reduces medical cost.

Universal Medical, as the China general agent of these two products, leveraging on its diversified healthcare resources network across the world and years of experience in healthcare area, has established its unique resources platform, advanced technology and equipment sourcing channels which appropriately matches domestic health development. We are fully confident to provide more assistance to boost China’s anesthesiology development and the overall growth of China’s healthcare industry.